Browse > Article
http://dx.doi.org/10.5352/JLS.2018.28.1.116

The Influence of the Sympathetic Nervous System on the Development and Progression of Cancer  

Park, Shin-Hyung (Department of Pathology, College of Korean Medicine, Dongeui University)
Chi, Gyoo-Yong (Department of Pathology, College of Korean Medicine, Dongeui University)
Choi, Yung Hyun (Department of Biochemistry, College of Korean Medicine, Dongeui University)
Publication Information
Journal of Life Science / v.28, no.1, 2018 , pp. 116-129 More about this Journal
Abstract
Living creatures possess long-conserved mechanisms to maintain homeostasis in response to various stresses. However, chronic and continuous exposure to stress can result in the excessive production of stress hormones, including catecholamines, which have harmful effects on health. Studies on the relationship between the sympathetic nervous system (SNS) and cancer have been conducted based on the traditional hypothesis that stress can promote cancer progression. Many preclinical and epidemiological studies have suggested that the regulation of ${\beta}$-adrenergic signaling, which mediates SNS activity, can suppress the progression of solid tumors. SNS activation has highly pleiotropic effects on tumor biology, as it stimulates oncogenes, survival pathways, the epithelial - mesenchymal transition, and invasion. Moreover, it inhibits DNA repair and programmed cell death and regulates the tumor microenvironment, including immune cells, endothelial cells, the extracellular matrix, mesenchymal cells, and adipocytes. Although targeted therapies on the molecular basis of tumor proliferation are currently receiving increased attention, they have clinical limitations, such as the compensatory activation of other signaling pathways, emergence of drug resistance, and various side effects, which raise the need for pleiotropic cancer regulation. This review summarizes the effects of the SNS on the development and progression of cancer and discusses the clinical perspectives of ${\beta}$-blockade as a novel therapeutic strategy for this disease.
Keywords
${\beta}$-adrenergic signaling; cancer progression; catecholamines; stress; sympathetic nervous system;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chang, M., Brown, H. J., Collado-Hidalgo, A., Arevalo, J. M., Galic, Z., Symensma, T. L., Tanaka, L., Deng, H., Zack, J. A., Sun, R. and Cole, S. W. 2005. ${\beta}$-adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J. Virol. 79, 13538-13547.   DOI
2 Chida, Y., Hamer, M., Wardle, J. and Steptoe, A. 2008. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5, 466-475.   DOI
3 Cirillo, D., Rachiglio, D. A. M., la Montagna R, Giordano, A. and Normanno, N. 2008. Leptin signaling in breast cancer: an overview. J. Cell. Biochem. 105, 956-964.   DOI
4 Cole, S. W. 2011. Beta-adrenergic regulation of gene expression in cancer. In: Proceeding of the 102nd Annual Meetingofthe American Association for Cancer Research.
5 Cole, S. W. 2013. Social regulation of human gene expression: mechanisms and implications for public health. Am. J. Publ. Health 103, S84-S92.   DOI
6 Cole, S. W. 2013. Nervous system regulation of the cancer genome. Brain Behav. Immun. 30, S10-S18.   DOI
7 Cole, S. W. 2014. Human social genomics. PLoS Genet. 10, e1004601.   DOI
8 Cole, S. W., Korin, Y. D., Fahey, J. L. and Zack, J. A. 1998. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161, 610-616.
9 Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A. and Sood, A. K. 2015. Sympathetic nervous system regulation of the tumour microenvironment. Nat. Rev. Cancer. 15, 563-572.   DOI
10 Cole, S. W. and Sood, A. K. 2012. Molecular pathways: beta- adrenergic signaling in cancer. Clin. Cancer Res. 5, 1201- 1206.
11 Collado-Hidalgo, A., Sung, C. and Cole, S. 2006. Adrenergic inhibition of innate anti-viral response: PKA blockade of type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav. Immun. 20, 552-563.   DOI
12 Cook-Mills, J. M., Mokyr, M. B., Cohen, R. L., Perlman, R. L. and Chambers, D. A. 1995. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunol. Immunother. 2, 79-87.
13 Creed, S. J., Le, C. P., Hassan, M., Pon, C. K., Albold, S., Chan, K. T., Berginski, M. E., Huang, Z., Bear, J. E., Lane, J. R., Halls, M. L., Ferrari, D., Nowell, C. J. and Sloan, E. K. 2015. ${\beta}$2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res. 17, 145.   DOI
14 Dal Monte, M., Casini, G., Filippi, L., Nicchia, G. P., Svelto, M. and Bagnoli, P. 2013. Functional involvement of ${\beta}$3-adrenergic receptors in melanoma growth and vascularization. J. Mol. Med. 91, 1407-1419.   DOI
15 Damon, D. H., Teriele, J. A. and Marko, S. B. 2007. Vascularderived artemin: a determinant of vascular sympathetic innervation? Am. J. Physiol. 293, H266-273
16 De Giorgi, V., Gandini, S., Grazzini, M., Benemei, S., Marchionni, N. and Geppetti, P. 2013. Effect of ${\beta}$-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death. Mayo Clin. Proc. 88, 1196-1203.   DOI
17 De Giorgi, V., Grazzini, M., Gandini, S., Benemei, S., Lotti, T., Marchionni, N. and Geppetti, P. 2011. Treatment with b-blockers and reduced disease progression in patients with thick melanoma. Arch. Intern. Med. 171, 779-781.
18 Deng, G. H., Liu, J., Zhang, J., Wang, Y., Peng, X. C., Wei, Y. Q. and Jiang, Y. 2014. Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model. J. Exp. Clin. Cancer Res. 33, 21.   DOI
19 Szpunar, M. J., Burke, K. A., Dawes, R. P., Brown, E. B. and Madden, K. S. 2013. The antidepressant desipramine and ${\alpha}$2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure. Cancer Prev. Res. 6, 1262-1272.   DOI
20 Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E., Lopez-Berestein, G., Schaller, M. D., Cole, S. W. and Lutgendorf, S. K. 2010. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J. Clin. Invest. 120, 1515-1523.   DOI
21 Wauters, M., Considine, R. V. and Van Gool, L. F. 2000. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur. J. Endocrionol. 143, 293-311.   DOI
22 Heidt, T., Sager, H. B., Courties, G., Dutta, P., Iwamoto, Y., Zaltsman, A., von Zur Muhlen C., Bode, C., Fricchione, G. L., Denninger, J., Lin, C. P., Vinegoni, C., Libby, P., Swirski, F. K., Weissleder, R. and Nahrendorf, M. 2014. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754-758.   DOI
23 Hermes, G. L., Delgado, B., Tretiakova, M., Cavigelli, S. A., Krausz, T., Conzen, S. D. and McClintock, M. K. 2009. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc. Natl. Acad. Sci. USA 106, 22393-22398.   DOI
24 Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W. and Sood, A. K. 2006. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939-944.   DOI
25 Voss, M. J. and Entschladen, F. 2010. Tumor interactions with soluble factors and the nervous system. Cell Commun. Signal 8, 21.   DOI
26 Watkins, J. L., Thaker, P. H., Nick, A. M., Ramondetta, L. M., Kumar, S., Urbauer, D. L., Matsuo, K., Squires, K. C., Coleman, R. L., Lutgendorf, S. K., Ramirez, P. T. and Sood, A. K. 2015. Clinical impact of selective and non-selective ${\beta}$-blockers on survival in patients with ovarian cancer. Cancer 121, 3444-3451.   DOI
27 Inbar, S., Neeman, E., Avraham, R., Benish, M., Rosenne, E. and Ben-Eliyahu, S. 2011. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 6, e19246.   DOI
28 Hori, Y., Ishii, K., Kanda, H., Iwamoto, Y., Nishikawa, K., Soga, N., Kise, H., Arima, K. and Sugimura, Y. 2011. Naftopidil, a selective ${\alpha}1$-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma. Cancer Prev. Res. 4, 87-96.   DOI
29 Horowitz, M., Neeman, E., Sharon, E. and Ben-Eliyahu, S. 2015. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat. Rev. Clin. Oncol. 12, 213-226.   DOI
30 Huang, S. and Ingber, D. E. 2005. Cell tension, matrix mechanics, and cancer development. Cancer Cell 3, 175-176.
31 Irwin, M. R. and Cole, S. W. 2011. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11, 625-632.   DOI
32 Jimenez-Andrade, J. M., Bloom, A. P., Stake, J. I., Mantyh, W. G., Taylor, R. N., Freeman, K. T., Ghilardi, J. R., Kuskowski, M. A. and Mantyh, P. W. 2010. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J. Neurosci. 30, 14649-14659.   DOI
33 Garofalo, C. and Surmacz, E. 2006. Leptin and cancer. J. Cell. Physiol. 207, 12-22.   DOI
34 Weiner, H. 1992. Perturbing the Organism: The Biology of Stressful Experience, Univ. of Chicago Press, Chicago, USA.
35 Wingenfeld, K., Whooley, M. A., Neylan, T. C., Otte, C. and Cohen, B. E. 2015. Effect of current and lifetime posttraumatic stress disorder on 24-h urinary catecholamines and cortisol: results from the Mind Your Heart Study. Psychoneuroendocrinology 52, 83-91.   DOI
36 Flint, M. S., Baum, A., Episcopo, B., Knickelbein, K. Z., Liegey Dougall, A. J., Chambers, W. H. and Jenkins, F. J. 2013. Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts. Stress 16, 114-121.   DOI
37 Friedman, G. D., Udaltsova, N. and Habel, L. A. 2011. Norepinephrine antagonists and cancer risk. Int. J. Cancer 128, 737-738.
38 Fridman, W. H., Pages, F., Sautes-Fridman, C. and Galon, J. 2012. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 4, 298-306.
39 Ganz, P. A. and Cole, S. W. 2011. Expanding our therapeutic options: ${\beta}$ blockers for breast cancer? J. Clin. Oncol. 29, 2612-2616.   DOI
40 Gogas, H., Trakatelli, M., Dessypris, N., Terzidis, A., Katsambas, A., Chrousos, G. P. and Petridou, E. T. 2008. Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann. Oncol. 19, 384-389.   DOI
41 Yang, E. V., Sood, A. K., Chen, M., Li, Y., Eubank, T. D., Marsh, C. B., Jewell, S., Flavahan, N. A., Morrison, C., Yeh, P. E., Lemeshow, S. and Glaser, R. 2006. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66, 10357- 10364.   DOI
42 Armaiz-Pena, G. N., Allen, J. K., Cruz, A., Stone, R. L., Nick, A. M., Lin, Y. G., Han, L. Y., Mangala, L. S., Villares, G. J., Vivas-Mejia, P., Rodriguez-Aguayo, C., Nagaraja, A. S., Gharpure, K. M., Wu, Z., English, R. D., Soman, K. V., Shahzad, M. M., Zigler, M., Deavers, M. T., Zien, A., Soldatos, T. G., Jackson, D. B., Wiktorowicz, J. E., Torres- Lugo, M., Young, T., De Geest, K., Gallick, G. E., Bar-Eli, M., Lopez-Berestein, G., Cole, S. W., Lopez, G. E., Lutgendorf, S. K. and Sood, A. K. 2013. Src activation by ${\beta}$-adrenoreceptors is a key switch for tumour metastasis. Nat. Commun. 4, 1403.   DOI
43 Armaiz-Pena, G. N., Cole, S. W., Lutgendorf, S. K. and Sood, A. K. 2013. Neuroendocrine influences on cancer progression. Brain Behav. Immun. 30, S19-S25.   DOI
44 Armaiz-Pena, G. N., Gonzalez-Villasana, V., Nagaraja, A. S., Rodriguez-Aguayo, C., Sadaoui, N. C., Stone, R. L., Matsuo, K., Dalton, H. J., Previs, R. A., Jennings, N. B., Dorniak, P., Hansen, J. M., Arevalo, J. M., Cole, S. W., Lutgendorf, S. K., Sood, A. K. and Lopez-Berestein, G. 2015. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. Oncotarget 6, 4266-4273.
45 Wolter, J. K., Wolter, N. E., Blanch, A., Partridge, T., Cheng, L., Morgenstern, D. A., Podkowa, M., Kaplan, D. R. and Irwin, M. S. 2014. Anti-tumor activity of the ${\beta}$-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget 5, 161-172.
46 Xu, Q., Wang, Z., Chen, X., Duan, W., Lei, J., Zong, L., Li, X., Sheng, L., Ma, J., Han, L., Li, W., Zhang, L., Guo, K., Ma, Z., Wu, Z., Wu, E. and Ma, Q. 2015. Stromal-derived factor-$1{\alpha}$/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Oncotarget 6, 4717-4732.
47 Yang, E. V., Kim, S. J., Donovan, E. L., Chen, M., Gross, A. C., Webster Marketon, J. I., Barsky, S. H. and Glaser, R. 2009. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav. Immun. 23, 267-275.   DOI
48 Yang, Z. F., Ho, D. W., Lam, C. T., Luk, J. M., Lum, C. T., Yu, W. C., Poon, R. T. and Fan, S. T. 2005. Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res. 65, 21925.
49 Glaser, R. and Kiecolt-Glaser J. K. 2005. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5, 243-251.   DOI
50 Goldfarb, Y., Sorski, L., Benish, M., Levi, B., Melamed, R. and Ben-Eliyahu, S. 2011. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann. Surg. 253, 798-810.   DOI
51 Grytli, H. H., Fagerland, M. W., Fossa, S. D., Tasken, K. A. and Haheim, L. L. 2013. Use of ${\beta}$-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate 73, 250-260.   DOI
52 Botteri, E., Munzone, E., Rotmensz, N., Cipolla, C., De Giorgi, V., Santillo, B., Zanelotti, A., Adamoli, L., Colleoni, M., Viale, G., Goldhirsch, A. and Gandini, S. 2013. Therapeutic effect of ${\beta}$-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res. Treat. 140, 567-575.   DOI
53 Ayala, G. E., Dai, H., Powell, M., Li, R., Ding, Y., Wheeler, T. M., Shine, D., Kadmon, D., Thompson, T., Miles, B. J., Ittmann, M. M. and Rowley, D. 2008. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin. Cancer Res. 14, 7593-7603.   DOI
54 Aydiner, A., Ciftci, R., Karabulut, S. and Kilic, L. 2013. Does ${\beta}$-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer? Asian Pac. J. Cancer Prev. 14, 6109-6114.   DOI
55 Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K. and Visvanathan, K. 2011. ${\beta}$ blockers and breast cancer mortality: a population-based study. J. Clin. Oncol. 29, 2635-2644.   DOI
56 Boluyt, M. O., Long, X., Eschenhagen, T., Mende, U., Schmitz, W., Crow, M. T. and Lakatta, E. G. 1995. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol. 2, H638-647.
57 Bonnans, C., Chou, J. and Werb, Z. 2014. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 12, 786-801.
58 Boucek, R. J. Jr., Kirsh, A. L., Majesky, M. W. and Perkins, J. A. 2013. Propranolol responsiveness in vascular tumors is not determined by qualitative differences in adrenergic receptors. Otolaryngol. Head Neck Surg. 149, 772-776.   DOI
59 Boyd, A. L., Salleh, A., Humber, B., Yee, J., Tomes, L. and Kerr, L. R. 2010. Neonatal experiences differentially infl uence mammary gland morphology, estrogen receptor a protein levels, and carcinogenesis in BALB/c mice. Cancer Prev. Res. (Phila) 3, 1398-1408.   DOI
60 Zage, P. E., Graham, T. C., Zeng, L., Fang, W., Pien, C., Thress, K., Omer, C., Brown, J. L. and Zweidler-McKay, P. A. 2011. The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan. Cancer 117, 1321-1391.   DOI
61 Hara, M. R., Kovacs, J. J., Whalen, E. J., Rajagopal, S., Strachan, R. T., Grant, W., Towers, A. J., Williams, B., Lam, C. M., Xiao, K., Shenoy, S. K., Gregory, S. G., Ahn, S., Duckett, D. R. and Lefkowitz, R. J. 2011. A stress response pathway regulates DNA damage through ${\beta}2$-adrenoreceptors and ${\beta}$-arrestin-1. Nature 477, 349-353.   DOI
62 Bronzetti, E., Artico, M., Forte, F., Pagliarella, G., Felici, L. M., D'Ambrosio, A., Vespasiani, G. and Bronzetti, B. 2008. A possible role of BDNF in prostate cancer detection. Oncol. Rep. 19, 969-974.
63 Zhang, J., Deng, Y. T., Liu, J., Wang, Y. Q., Yi, T. W., Huang, B. Y., He, S. S., Zheng, B. and Jiang, Y. 2016. Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro. J. Cancer Res. Clin. Oncol. 142, 423-435.   DOI
64 Zhang, X., Odom, D. T., Koo, S. H., Conkright, M. D., Canettieri, G., Best, J., Chen, H., Jenner, R., Herbolsheimer, E., Jacobsen, E., Kadam, S., Ecker, J. R., Emerson, B., Hogenesch, J. B., Unterman, T., Young, R. A. and Montminy, M. 2005. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102, 4459-4464.   DOI
65 Zur Hausen, H. 2008. Infections causing human cancer. Wiley-VCH, NJ, USA.
66 Grytli, H. H., Fagerland, M. W., Fossa, S. D. and Tasken, K. A. 2014. Association between use of ${\beta}$-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur. Urol. 65, 635-641.   DOI
67 Guo, K. Ma, Q., Li, J., Wang, Z., Shan, T., Li, W., Xu, Q. And Xie, K. 2013. Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Mol. Cancer Ther. 12, 264-273.   DOI
68 Hanoun, M., Maryanovich, M., Arnal-Estape, A. and Frenette, P. S. 2015. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron 86, 360-373.   DOI
69 Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M. and Sood, A. K. 2006. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6, 240-248.   DOI
70 Adriaenssens, E., Vanhecke, E., Saule, P., Mougel, A., Page, A., Romon, R., Nurcombe, V., Le Bourhis, X. and Hondermarck, H. 2008. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 68, 346-351.   DOI
71 Cao, L. Liu, X., Lin, E. J., Wang, C., Choi, E. Y., Riban, V., Lin, B. and During, M. J. 2010. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 142, 52-64.   DOI
72 Bruzzone, A. Pinero, C. P., Rojas, P., Romanato, M., Gass, H., Lanari, C. and Lüthy, I. A. 2011. ${\alpha}$2-adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells. Curr. Cancer Drug Targets 11, 763-774.   DOI
73 Burger, R., Bakker, F., Guenther, A., Baum, W., Schmidt Arras, D., Hideshima, T., Tai, Y. T., Shringarpure, R., Catley, L., Senaldi, G. Gramatzki, M. and Anderson, K. C. 2003. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival. Brit. J. Haematol. 123, 869-878.   DOI
74 Calvani, M., Pelon, F., Comito, G., Taddei, M. L., Moretti, S., Innocenti, S., Nassini, R., Gerlini, G., Borgognoni, L., Bambi, F., Giannoni, E., Filippi, L. and Chiarugi, P. 2015. Norepinephrine promotes tumor microenvironment reactivity through ${\beta}$3-adrenoreceptors during melanoma progression. Oncotarget 6, 4615-4632.
75 Cao, L. and During, M. J. 2012. What is the brain-cancer connection? Annu. Rev. Neurosci. 35, 331-345.   DOI
76 Chakroborty, D., Sarkar, C., Basu, B., Dasgupta, P. S. and Basu, S. 2009. Catecholamines regulate tumor angiogenesis. Cancer Res. 69, 3727-3730.   DOI
77 Shi, M., Liu, D., Duan, H., Qian, L., Wang, L., Niu, L., Zhang, H., Yong, Z., Gong, Z., Song, L., Yu, M., Hu, M., Xia, Q., Shen, B. and Guo, N. 2011. The ${\beta}$2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res. Treat. 125, 351-362.   DOI
78 Hara, M. R., Sachs, B. D., Caron, M. G. and Lefkowitz, R. J. 2013. Pharmacological blockade of a ${\beta}2AR$-${\beta}arrestin$-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model. Cell Cycle 12, 219-224.   DOI
79 Hasegawa, H. and Saiki, I. 2002. Psychosocial stress augments tumor development through ${\beta}$-adrenergic activation in mice. Jpn. J. Cancer Res. 93, 729-735.   DOI
80 Hassan, S., Karpova, Y., Baiz, D., Yancey, D., Pullikuth, A., Flores, A., Register, T., Cline, J. M., D'Agostino, R. Jr., Danial, N. Datta, S. R. and Kulik, G. 2013. Behavioral stress accelerates prostate cancer development in mice. J. Clin. Invest. 123, 874-886.
81 Sklar, L. S. and Anisman, H. 1979. Stress and coping factors influence tumor growth. Science 205, 513-515.   DOI
82 Simon, R. H., Lovett, E. J., Tomaszek, D. and Lundy, J. 1980. Electrical stimulation of the midbrain mediates metastatic tumor growth. Science 209, 1132-1133.   DOI
83 Sloan, E. K., Capitanio, J. P., Tarara, R. P., Mendoza, S. P., Mason, W. A. and Cole, S. W. 2007. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J. Neurosci. 27, 8857-8865.   DOI
84 Sloan, E. K., Capitanio, J. P. and Cole, S. W. 2008. Stress-induced remodeling of lymphoid innervation. Brain Behav. Immun. 22, 15-21.
85 Sloan, E. K., Capitanio, J. P., Tarara, R. P. and Cole, S. W. 2008. Social temperament and lymph node innervation. Brain Behav. Immun. 22, 717-726.   DOI
86 Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M., Morizono, K., Karanikolas, B. D., Wu, L., Sood, A. K. and Cole, S. W. 2010. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 18, 7042-7052.
87 Sood, A. K., Bhatty, R., Kamat, A. A., Landen, C. N., Han, L., Thaker, P. H., Li, Y., Gershenson, D. M., Lutgendorf, S. and Cole, S. W. 2006. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 12, 369-375.   DOI
88 Diaz, E. S., Karlan, B. Y. and Li, A. J. 2012. Impact of ${\beta}$ blockers on epithelial ovarian cancer survival. Gynecol. Oncol. 127, 375-378.   DOI
89 Antoni, M. H., Lutgendorf, S. K., Blomberg, B., Carver, C. S., Lechner, S., Diaz, A., Stagl, J., Arevalo, J. M. and Cole, S. W. 2012. Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics. Biol. Psychiatry 71, 366-372.   DOI
90 De Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A. and Bos, J. L. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477.   DOI
91 Drell, T. L., Joseph, J., Lang, K., Niggemann, B., Zaenker, K. S. and Entschladen, F. 2003. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res. Treat. 80, 63-70.   DOI
92 Eichmann, A. and Thomas, J. L. 2013. Molecular parallels between neural and vascular development. Cold Spring Harb. Perspect. Med. 3, a006551.
93 Elenkov, I. J., Wilder, R. L., Chrousos, G. P. and Vizi, E. S. 2000. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638.
94 Eng, J. W., Reed, C. B., Kokolus, K. M., Pitoniak, R., Utley, A., Bucsek, M. J., Ma, W. W., Repasky, E. A. and Hylander, B. L. 2015. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through ${\beta}2-$ adrenergic receptor activation. Nat. Commun. 6, 6426.   DOI
95 Lang, K., Drell, T. L. 4th., Lindecke, A., Niggemann, B., Kaltschmidt, C., Zaenker, K. S. and Entschladen, F. 2004. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int. J. Cancer 112, 231-238.   DOI
96 Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q. T. and Giaccia, A. J. 2009. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 1, 35-44.
97 Flierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., McGuire, S. R., List, R. P., Day, D. E., Hoesel, L. M., Gao, H., Van Rooijen, N., Huber-Lang, M. S., Neubig, R. R. and Ward, P. A. 2007. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725.   DOI
98 Neeman, E., Zmora, O. and Ben-Eliyahu, S. 2012. A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin. Cancer Res. 18, 4895-4902.   DOI
99 Lamkin, D. M., Sloan, E. K., Patel, A. J., Chiang, B. S., Pimentel, M. A., Ma, J. C., Arevalo, J. M., Morizono, K. and Cole, S. W. 2012. Chronic stress enhances progression of acute lymphoblastic leukemia via ${\beta}$-adrenergic signaling. Brain Behav. Immun. 26, 635-641.   DOI
100 Lamkin, D. M., Sung, H. Y., Yang, G. S., David, J. M., Ma, J. C., Cole, S. W. and Sloan, E. K. 2015. ${\alpha}2$-adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression. Psychoneuroendocrinology 51, 262-270.   DOI
101 Landen, C. N. Jr., Lin, Y. G., Armaiz Pena, G. N., Das, P. D., Arevalo, J. M., Kamat, A. A., Han, L. Y., Jennings, N. B., Spannuth, W. A., Thaker, P. H., Lutgendorf, S. K., Savary, C. A., Sanguino, A. M., Lopez-Berestein, G., Cole, S. W. and Sood, A. K. 2007. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 67, 10389-10396.   DOI
102 Luttrell, L. M., Ferguson, S. S., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D. K., Caron, M. G. and Lefkowitz, R. J. 1999. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.   DOI
103 Lemeshow, S. Sorensen, H. T., Phillips, G., Yang, E. V., Antonsen, S., Riis, A. H., Lesinski, G. B., Jackson, R. and Glaser, R. 2011. ${\beta}$-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol. Biomarkers Prev. 20, 2273-2279.   DOI
104 Leonardo, E. D., Hinck, L., Masu, M., Keino-Masu, K., Ackerman, S. L. and Tessier-Lavigne, M. 1997. Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386, 833-838.   DOI
105 Liu, J., Deng, G. H., Zhang, J., Wang, Y., Xia, X. Y., Luo, X. M., Deng, Y. T., He, S. S., Mao, Y. Y., Peng, X. C., Wei, Y. Q. and Jiang, Y. 2015. The effect of chronic stress on antiangiogenesis of sunitinib in Lu colorectal cancer models. Psychoneuroendocrinology 52, 130-142.   DOI
106 Lu, P., Weaver, V. M. and Werb, Z. 2012. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 4, 395-406.
107 Lutgendorf, S. K., DeGeest, K., Sung, C. Y., Arevalo, J. M., Penedo, F., Lucci, J., Goodheart, M., Lubaroff, D., Farley, D. M., Sood, A. K. and Cole, S. W. 2009. Depression, social support, and ${\beta}$-adrenergic transcription control in human ovarian cancer. Brain Behav. Immun. 23, 176-183.   DOI
108 Lutgendorf, S. K., DeGeest, K., Dahmoush, L., Farley, D., Penedo, F., Bender, D., Goodheart, M., Buekers, T. E., Mendez, L., Krueger, G., Clevenger, L., Lubaroff, D. M., Sood, A. K. and Cole, S. W. 2011. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav. Immun. 25, 250-255.   DOI
109 Lutgendorf, S. K., Sood, A. K. and Antoni, M. H. 2010. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J. Clin. Oncol. 28, 4094- 4099.   DOI
110 Madden, K. S., Szpunar, M. J. and Brown, E. B. 2011. ${\beta}$- adrenergic receptors (${\beta}$-AR) regulate VEGF and IL-6 production by divergent pathways in high ${\beta}$-AR-expressing breast cancer cell lines. Breast Cancer Res. Treat. 130, 747-758.   DOI
111 Penninx, B. W., Guralnik, J. M., Pahor, M., Ferrucci, L., Cerhan, J. R., Wallace, R. B. and Havlik, R. J. 1998. Chronically depressed mood and cancer risk in older persons. J. Nat. Cancer Inst. 90, 1888-1893.   DOI
112 Reiche, E. M., Nunes, S. O. and Morimoto, H. K. 2004. Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617-625.   DOI
113 Peters, L. J. and Kelly, H. 1977. The influence of stress and stress hormones on the transplantability of a non-immunogenic syngeneic murine tumor. Cancer 39, 14828.
114 Powe, D. G., Voss, M. J., Zanker, K. S., Habashy, H. O., Green, A. R., Ellis, I. O. and Entschladen, F. 2010. Betablocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1, 628-638.
115 Powell, N. D., Sloan, E. K., Bailey, M. T., Arevalo, J. M., Miller, G. E., Chen, E., Kobor, M. S., Reader, B. F., Sheridan, J. F. and Cole, S. W. 2013. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via ${\beta}$-adrenergic induction of myelopoiesis. Proc. Natl. Acad. Sci. USA 110, 16574-16579.   DOI
116 Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M. C., Validire, P., Trautmann, A. Mami-Chouaib, F. and Donnadieu, E. 2012. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest. 3, 899-910.
117 Sastry, K. S., Karpova, Y., Prokopovich, S., Smith, A. J., Essau, B., Gersappe, A., Carson, J. P., Weber, M. J., Register, T. C., Chen, Y. Q., Penn, R. B. and Kulik, G. 2007. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J. Biol. Chem. 282, 14094-14100.   DOI
118 Scheiermann, C., Kunisaki, Y. and Frenette, P. S. 2013. Circadian control of the immune system. Nat. Rev. Immunol. 13, 190-198.   DOI
119 Kohm, A. P. and Sanders, V. M. 2001. Norepinephrine and ${\beta}$ 2-adrenergic receptor stimulation regulate $CD4^+$ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53, 487-525.
120 Kitamura, T., Qian, B. Z. and Pollard, J. W. 2015. Immune cell promotion of metastasis. Nat. Rev. Immunol. 2, 73-86.
121 Kruttgen, A., Schneider, I. and Weis, J. 2006. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol. 16, 304-310.   DOI
122 Kulik, G. A., Hassan, S., Karpova, Y. and Baurin, V. 2011. Behavioral stress protects prostate cancer cells from apoptosis. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research.
123 Lai, P. C., Chiu, T. H. and Huang, Y. T. 2010. Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol. Rep. 24, 1265-1270.
124 Palm, D., Lang, K., Niggemann, B., Drell, T. L., Masur, K., Zaenker, K. S. and Entschladen, F. 2006. The norepinephrine- driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by ${\beta}$-blockers. Int. J. Cancer 118, 2744-2749.   DOI
125 Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J. and Frenette, P. S. 2013. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361.   DOI
126 Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. 2008. Cancer-related inflammation. Nature 7203, 436-444.
127 Makita, T., Sucov, H. M., Gariepy, C. E., Yanagisawa, M. and Ginty, D. D. 2008. Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons. Nature 452, 759-763.   DOI
128 Nilsson, M. B., Armaiz-Pena, G., Takahashi, R., Lin, Y. G., Trevino, J., Li, Y., Jennings, N., Arevalo, J., Lutgendorf, S. K., Gallick, G. E., Sanguino, A. M., Lopez-Berestein, G., Cole, S. W. and Sood, A. K. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J. Biol. Chem. 282, 29919-29926.   DOI
129 Ohta, T., Numata, M., Tsukioka, Y., Futagami, F., Kayahara, M., Kitagawa, H., Nagakawa, T., Yamamoto, M., Wakayama, T., Kitamura, Y., Terada, T. and Nakanuma, Y. 1997. Neurotrophin-3 expression in human pancreatic cancers. J. Pathol. 181, 405-412.   DOI
130 Pongratz, G. and Straub, R. H. 2014. The sympathetic nervous response in inflammation. Arthritis Res. Ther. 6, 504.
131 Pasquier, E., Street, J., Pouchy, C., Carre, M., Gifford, A. J., Murray, J., Norris, M. D., Trahair, T., Andre, N. and Kavallaris, M. 2013. ${\beta}$-blockers increase response to chemotherapy via direct antitumour and antiangiogenic mechanisms in neuroblastoma. Br. J. Cancer 108, 2485-2494.   DOI
132 Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66, 807-822.   DOI
133 McGregor, L. M., McCune, B. K., Graff, J. R., McDowell, P. R., Romans, K. E., Yancopoulos, G. D., Ball, D. W., Baylin, S. B. and Nelkin, B. D. 1999. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc. Nat. Acad. Sci. USA 96, 4540-4545.   DOI
134 Melhem-Bertrandt, A., Chavez-Macgregor, M., Lei, X., Brown, E. N., Lee, R. T., Meric-Bernstam, F., Sood, A. K., Conzen, S. D., Hortobagyi, G. N. and Gonzalez-Angulo, A. M. 2011. ${\beta}$-blocker use is associated with improved relapse- free survival in patients with triple-negative breast cancer. J. Clin. Oncol. 29, 2645-2652.   DOI
135 Minchinton, A. I. and Tannock, I. F. 2006. Drug penetration in solid tumours. Nat. Rev. Cancer 8, 583-592.
136 Mantyh, W. G., Jimenez-Andrade, J. M., Stake, J. I., Bloom, A. P., Kaczmarska, M. J., Taylor, R. N., Freeman, K. T., Ghilardi, J. R., Kuskowski, M. A. and Mantyh, P. W. 2010. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 171, 588-598.   DOI
137 Nakai, A., Hayano, Y., Furuta, F., Noda, M. and Suzuki, K. 2014. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J. Exp. Med. 13, 2583- 2598.
138 Katayama, Y., Battista, M., Kao, W. M., Hidalgo, A., Peired, A. J., Thomas, S. A. and Frenette, P. S. 2006. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421.   DOI
139 Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A. Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., Hammer, D. A. and Weaver, V. M. 2005. Tensional homeostasis and the malignant phenotype. Cancer Cell 3, 241-254.
140 Kalinichenko, V. V., Mokyr, M. B., Graf, L. H. Jr., Cohen, R. L. and Chambers, D. A. 1999. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J. Immunol. 5, 2492- 2499.
141 Shanley, C. J., Gharaee-Kermani, M., Sarkar, R., Welling, T. H., Kriegel, A., Ford, J. W., Stanley, J. C. and Phan, S. H. 1997. Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J. Vasc. Surg. 3, 446-452.
142 Keino-Masu, K., Masu, M., Hinck, L., Leonardo, E. D., Chan, S. S., Culotti, J. G. and Tessier-Lavigne, M. 1996. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 87, 175-185.   DOI
143 Kim-Fuchs, C., Le, C. P., Pimentel, M. A., Shackleford, D., Ferrari, D., Angst, E., Hollande, F. and Sloan, E. K. 2014. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for ${\beta}$-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40-47.   DOI
144 Seo, B. R., Bhardwaj, .P., Choi, S., Gonzalez, J., Andresen Eguiluz, R. C., Wang, K., Mohanan, S., Morris, P. G., Du, B., Zhou, X. K., Vahdat, L. T., Verma, A., Elemento, O., Hudis, C. A., Williams, R. M., Gourdon, D., Dannenberg, A. J. and Fischbach, C. 2015. Obesitydependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci. Transl. Med. 7, 301ra130.   DOI
145 Shah, S. M., Carey, I. M., Owen, C. G., Harris, T., Dewilde, S. and Cook, D. G. 2011. Does b-adrenoceptor blocker therapy improve cancer survival? Findings from a populationbased retrospective cohort study. Br. J. Clin. Pharmacol. 72, 157-161.   DOI
146 Schuler, L. A. and Auger, A. P. 2010. Psychosocially infl uenced cancer : diverse early life stress experiences and links to breast cancer. Cancer Prev. Res. (Phila) 3, 1365-1370.   DOI
147 Shahzad, M. M., Arevalo, J. M., Armaiz-Pena, G. N., Lu, C., Stone, R. L., Moreno-Smith, M., Nishimura, M., Lee, J. W., Jennings, N. B., Bottsford-Miller, J. Vivas-Mejia, P., Lutgendorf, S. K., Lopez-Berestein, G., Bar-Eli, M., Cole, S. W. and Sood, A. K. 2010. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J. Biol. Chem. 285, 35462-35470.   DOI
148 Shakhar, G. and Ben-Eliyahu, S. 1998. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 7, 3251-3258.
149 Shan, T., Cui, X., Li, W., Lin, W., Li, Y., Chen, X. and Wu, T. 2014. Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines. Cancer Sci. 105, 847-856.   DOI